SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A critical review of methods to evaluate the impact of FDA regulatory actions
6 references·1 citing·32 second hop
A critical review of methods to evaluate the impact of FDA regulatory actions (2013)A critical review of methods to evaluate …Persisting Decline in Depression Treatment After FDA Warnings (2009)Persisting Decline in Depress…Cochrane Handbook for Systematic Reviews of Interventions (2008)Cochrane Handbook for Systema…Spillover Effects on Treatment of Adult Depression in Primary Care After FDA Advisory on Risk of Pediatric Suicidality With SSRIs (2007)Spillover Effects on Treatmen…Impact of Publicity Concerning Pediatric Suicidality Data on Physician Practice Patterns in the United States (2007)Impact of Publicity Concernin…Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents (2007)Early Evidence on the Effects…STUDIES IN THE QUALITY OF LIFE; DELPHI AND DECISION-MAKING. (1972)STUDIES IN THE QUALITY OF LIF…Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators (2018)Listen to the public and fulf…Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The functioning and well-being of depressed patients. Results from the Medical Outcomes Study (1989)Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys (2004)Individual and Societal Effects of Mental Disorders on Earnings in the United States: Results From the National Comorbidity Survey Replication (2008)Anxiety, Depression, and Somatic Distress: Developing a Transdiagnostic Internalizing Toolbox for Pediatric Practice (2011)Antidepressants' Black-Box Warning — 10 Years Later (2014)Antidepressants and Suicidality (2016)The Functioning and Well-being of Depressed Patients (1989)Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development (2010)Practical Suicide-Risk Management for the Busy Primary Care Physician (2011)History of Psychopharmacology (2019)A Hundred Cases of Suicide: Clinical Aspects (1974)Suicide Prevention Strategies (2005)Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA’s Pediatric Suicidal Risk Analysis of Antidepressants (2007)World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision (2008)The neurobiology of suicide (2014)Treatment of anxiety disorders (2017)Vaccination greatly reduces disease, disability, death and inequity worldwide (2008)Effective Messages in Vaccine Promotion: A Randomized Trial (2014)Vaccine hesitancy: Definition, scope and determinants (2015)A public health timeline to prepare for COVID-19 vaccines in Canada (2020)Enhancing Delphi research: methods and results (2004)Methodological and conceptual issues confronting a cross-country Delphi study of educational program evaluation (2008)The use of Delphi and Nominal Group Technique in nursing education: A review (2016)Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults (2008)Effects of Food and Drug Administration Warnings on Antidepressant Use in a National Sample (2008)Outpatient Visits and Medication Prescribing for US Children With Mental Health Conditions (2015)
this work references cited by second hop

References

  • 2008Cochrane Handbook for Systematic Reviews of Interventions25,045 cited
  • 2007Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and Adolescents602 cited
  • 1972STUDIES IN THE QUALITY OF LIFE; DELPHI AND DECISION-MAKING.302 cited
  • 2007Impact of Publicity Concerning Pediatric Suicidality Data on Physician Practice Patterns in the United States206 cited
  • 2009Persisting Decline in Depression Treatment After FDA Warnings153 cited
  • 2007Spillover Effects on Treatment of Adult Depression in Primary Care After FDA Advisory on Risk of Pediatric Suicidality With SSRIs137 cited

Cited by

  • 2018Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators18 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work